Bairitone Health receives FDA Breakthrough Device Designation for its noninvasive technology designed for obstructive sleep apnea
Bairitone Health has received Breakthrough Device Designation from the US Food and Drug Administration (FDA) for its sleep sonar for anatomic polysomnography technology to pinpoint the root cause of airway obstruction in people with obstructive sleep apnea (OSA).